US Stock MarketDetailed Quotes

HSIC Henry Schein

Watchlist
  • 76.600
  • -0.430-0.56%
Close Dec 13 16:00 ET
  • 76.600
  • 0.0000.00%
Post 16:40 ET
9.55BMarket Cap31.39P/E (TTM)

About Henry Schein Company

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Company Profile

SymbolHSIC
Company NameHenry Schein
Listing DateNov 2, 1995
Issue Price16.00
Founded1932
CEOMr. Stanley M. Bergman
MarketNASDAQ
Employees25000
Fiscal Year Ends12-28
Address135 Duryea Road
CityMelville
ProvinceNew York
CountryUnited States of America
Zip Code11747
Phone1-631-843-5500

Company Executives

  • Name
  • Position
  • Salary
  • Stanley M. Bergman
  • Chairman of the Board and Chief Executive Officer
  • 10.01M
  • Andrea Albertini
  • Chief Executive Officer, International Distribution Group
  • --
  • Dr. Rene Willi, PhD
  • Chief Executive Officer, Global Oral Reconstruction Group
  • --
  • Brad Connett
  • Chief Executive Officer, North American Distribution Group
  • --
  • Ronald N. South
  • Senior Vice President, Principal Accounting Officer and Chief Financial Officer
  • 2.35M
  • Michael S. Ettinger
  • Executive Vice President and Chief Operating Officer
  • --
  • Walter Siegel
  • Senior Vice President and Chief Legal Officer
  • --
  • Christopher Pendergast
  • Senior Vice President and Chief Technology Officer
  • --
  • Trinh Clark
  • Senior Vice President and Chief Global Customer Experience Officer
  • --
  • Lorelei McGlynn
  • Senior Vice President and Chief Human Resources Officer
  • --
  • Leigh Benowitz
  • Senior Vice President and Chief Global Digital Transformation Officer
  • --
  • Mark E. Mlotek
  • Director, Executive Vice President and Chief Strategic Officer
  • 3.22M
  • Kelly Murphy
  • Senior Vice President and General Counsel
  • --
  • James Mullins
  • Senior Vice President, Global Supply Chain
  • --
  • Scott P. Serota
  • Independent Director
  • 276.00K
  • Dr. Reed V. Tuckson, M.D.
  • Independent Director
  • 269.40K
  • Carole T. Faig
  • Independent Director
  • 4.45K
  • Joseph L. Herring
  • Independent Director
  • 313.00K
  • Dr. Bradley T. Sheares, PhD
  • Independent Director
  • 304.20K
  • Carol Raphael
  • Independent Director
  • 282.60K
  • Philip A. Laskawy
  • Lead Independent Director
  • 335.40K
  • Deborah M. Derby
  • Independent Director
  • 304.80K
  • Mohamad Ali
  • Independent Director
  • 271.60K
  • Kurt P. Kuehn
  • Independent Director
  • 316.40K
  • Anne H. Margulies
  • Independent Director
  • 291.40K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.